Researcher

Katie Gilligan

About

We are creating new approach to treat currently incurable respiratory diseases. Our pipeline of advanced therapies intersect regenerative medicine and gene therapy in the hope of treating these devastating lung diseases of severely unmet patient need. Our platform technology is based on inhaled bioengineered stem cell exosomes which are capable of efficient intracellular delivery of a variety of therapeutic cargoes to effectively treat diseases including CF and lung cancer.

Katie Gilligan

Head of R&D
R&D 0874110714
kgilligan@omnispirant.com

Website

View Website

Address

Stradbally East, Kilcolgan, Galway,
Galway,
H91 D29F,
Ireland

0874110714
kgilligan@omnispirant.com

Areas of Expertise

  • Cell therapy (Allogeneic)
  • Clinical
  • Delivery
  • Gene Therapy (non-viral)
  • Manufacturing sciences
  • Process Development
  • RNA